CX3CL1 protects neurons against excitotoxicity enhancing GLT-1 activity on astrocytes

Journal of Neuroimmunology

Volumn 263, Issue 1-2, 2013, Pages 75-82

  Catalano, Myriam ^a,b   Lauro, Clotilde ^a   Cipriani, Raffaela ^a   Chece, Giuseppina ^a   Ponzetta, Andrea ^a   Di Angelantonio, Silvia ^a,c   Ragozzino, Davide ^a,b   Limatola, Cristina ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

^c ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

A1R; Astrocytes; CX3CL1; GLT 1; Microglia; Neuroprotection

Indexed keywords

8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; FRACTALKINE; SODIUM GLUCOSE COTRANSPORTER 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CELL CULTURE; COCULTURE; CONTROLLED STUDY; EXCITOTOXICITY; GLIA; GLUCOSE TRANSPORT; HIPPOCAMPUS; IN VITRO STUDY; MICROGLIA; NERVE CELL; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION;

A1R; ASTROCYTES; CX3CL1; GLT-1; MICROGLIA; NEUROPROTECTION;

ANIMALS; ANIMALS, NEWBORN; CELL SURVIVAL; CELLS, CULTURED; CHEMOKINE CX3CL1; COCULTURE TECHNIQUES; EXCITATORY AMINO ACID TRANSPORTER 2; GLUCOSE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; UP-REGULATION;

EID: 84884812500     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2013.07.020     Document Type: Article

References (51)

1. Amato A., Ballerini L., Attwell D. Intracellular pH changes produced by glutamate uptake in rat hippocampal slices. J. Neurophysiol. 1994, 72:1686-1696.
2. Anderson C.M., Swanson R.A. Astrocyte glutamate transport: review of properties, regulation and physiological functions. Glia 2000, 32:1-14.
3. Benediktsson A.M., Marrs G.S., Tu J.C., Worley P.F., Rothstein J.D., Bergles D.E., Dailey M.E. Neuronal activity regulates glutamate transporter dynamics in developing astrocytes. Glia 2012, 60:175-188.
4. Bhaskar K., Konerth M., Kokiko-Cochran O.N., Cardona A., Ransohoff R.M., Lamb B.T. Regulation of tau pathology by the microglial fractalkine receptor. Neuron 2010, 68:19-31.
5. Cardona A.E., Pioro E.P., Sasse M.E., Kostenko V., Cardona S.M., Dijkstra I.M., Huang D., Kidd G., Dombrowski S., Dutta R., Lee J.C., Cook D.N., Jung S., Lira S.A., Littman D.R., Ransohoff R.M. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 2006, 9:917-924.
6. Chu K., Lee S.T., Sinn D.I., Ko S.Y., Kim E.H., Kim J.M., Kim S.J., Park D.K., Jung K.H., Song E.C., Lee S.K., Kim M., Roh J.K. Pharmacological induction of ischemic tolerance by glutamate transporter-1 (EAAT2) upregulation. Stroke 2007, 38:177-182.
7. Cipriani R., Villa P., Chece G., Lauro C., Paladini A., Micotti E., Perego C., De Simoni M.G., Fredholm B.B., Eusebi F., Limatola C. CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents. J. Neurosci. 2011, 31:16327-16335.
8. Dénes A., Ferenczi S., Halász J., Környei Z., Kovács K.J. Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse. J. Cereb. Blood Flow Metab. 2008, 28:1707-1721.
9. Fredholm B.B., Chen J.F., Cunha R.A., Svenningsson P., Vaugeois J.M. Adenosine and brain function. Int. Rev. Neurobiol. 2005, 63:191-270.
10. Frizzo M.E., Frizzo J.K., Amadio S., Rodrigues J.M., Perry M.L., Bernardi G., Volonté C. Extracellular adenosine triphosphate induces glutamate transporter-1 expression in hippocampus. Hippocampus 2007, 17:305-315.
11. Fuhrmann M., Bittner T., Jung C.K., Burgold S., Page R.M., Mitteregger G., Haass C., LaFerla F.M., Kretzschmar H., Herms J. Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease. Nat. Neurosci. 2010, 13:411-413.
12. Halassa M.M., Fellin T., Haydon P.G. The tripartite synapse: roles for gliotransmission in health and disease. Trends Mol. Med. 2007, 13:54-63.
13. Harrison J.K., Jiang Y., Chen S., Xia Y., Maciejewski D., McNamara R.K., Streit W.J., Salafranca M.N., Adhikari S., Thompson D.A., Botti P., Bacon K.B., Feng L. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:10896-10901.
14. Hoek R.M., Ruuls S.R., Murphy C.A., Wright G.J., Goddard R., Zurawski S.M., Blom B., Homola M.E., Streit W.J., Brown M.H., Barclay A.N., Sedgwick J.D. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 2000, 290:1768-1771.
15. Huang D., Shi F.D., Jung S., Pien G.C., Wang J., Salazar-Mather T.P., He T.T., Weaver J.T., Ljunggren H.G., Biron C.A., Littman D.R., Ransohoff R.M. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J. 2006, 20:896-905.
16. Imasawa M., Kashiwagi K., Iizuka Y., Tanaka M., Tsukahara S. Different expression role among glutamate transporters in rat retinal glial cells under various culture conditions. Brain Res. Mol. Brain Res. 2005, 142:1-8.
17. Johansson B., Halldner L., Dunwiddie T.V., Masino S.A., Poelchen W., Giménez-Llort L., Escorihuela R.M., Fernández-Teruel A., Wiesenfeld-Hallin Z., Xu X.J., Hårdemark A., Betsholtz C., Herlenius E., Fredholm B.B. Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:9407-9412.
18. Jung S., Aliberti J., Graemmel P., Sunshine M.J., Kreutzberg G.W., Sher A., Littman D.R. Analysis of fractalkine receptor CX3CR1 function by targeted deletion and green fluorescent protein insertion. Mol. Cell. Biol. 2000, 20:4106-4114.
19. Kim K., Lee S.G., Kegelman T.P., Su Z.Z., Das S.K., Dash R., Dasgupta S., Barral P.M., Hedvat M., Diaz P., Reed J.C., Stebbins J.L., Pellecchia M., Sarkar D., Fisher P.B. Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. J. Cell. Physiol. 2011, 226:2484-2493.
20. Latini S., Pedata F. Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J. Neurochem. 2001, 79:463-484.
21. Lauro C., Di Angelantonio S., Cipriani R., Sobrero F., Antonilli L., Brusadin V., Ragozzino D., Limatola C. Activity of adenosine receptors type 1 Is required for CX3CL1-mediated neuroprotection and neuromodulation in hippocampal neurons. J. Immunol. 2008, 180:7590-7596.
22. Lauro C., Cipriani R., Catalano M., Trettel F., Chece G., Brusadin V., Antonilli L., van Rooijen N., Eusebi F., Fredholm B.B., Limatola C. Adenosine A1 receptors and microglial cells mediate CX3CL1-induced protection of hippocampal neurons against Glu-induced death. Neuropsychopharmacology 2010, 35:1550-1559.
23. Lee S.G., Su Z.Z., Emdad L., Gupta P., Sarkar D., Borjabad A., Volsky D.J., Fisher P.B. Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes. J. Biol. Chem. 2008, 283:13116-13123.
24. Lee M.R., Ruby C.L., Hinton D.J., Choi S., Adams C.A., Young Kang N., Choi D.S. Striatal adenosine signaling regulates EAAT2 and astrocytic AQP4 expression and alcohol drinking in mice. Neuropsychopharmacology 2013, 38:437-445.
25. Li X.X., Nomura T., Aihara H., Nishizaki T. Adenosine enhances glial glutamate efflux via A2a adenosine receptors. Life Sci. 2001, 68:1343-1350.
26. Limatola C., Lauro C., Catalano M., Ciotti M.T., Bertollini C., Di Angelantonio S., Ragozzino D., Eusebi F. Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity. J. Neuroimmunol. 2005, 166:19-28.
27. Matos M., Augusto E., Oliveira C.R., Agostinho P. Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades. Neuroscience 2008, 156:898-910.
28. Matos M., Augusto E., Santos-Rodrigues A.D., Schwarzschild M.A., Chen J.F., Cunha R.A., Agostinho P. Adenosine A(2A) receptors modulate glutamate uptake in cultured astrocytes and gliosomes. Glia 2012, 60:702-716.
29. Moisse K., Strong M.J. Innate immunity in amyotrophic lateral sclerosis. Biochim. Biophys. Acta 2006, 1762:1083-1093.
30. Nakajima K., Tohyama Y., Kohsaka S., Kurihara T. Ability of rat microglia to uptake extracellular glutamate. Neurosci. Lett. 2001, 307:171-174.
31. Nishizaki T., Nagai K., Nomura T., Tada H., Kanno T., Tozaki H., Li X.X., Kondoh T., Kodama N., Takahashi E., Sakai N., Tanaka K., Saito N. A new neuromodulatory pathway with a glial contribution mediated via A(2a) adenosine receptors. Glia 2002, 39:133-147.
32. Noda M., Doi Y., Liang J., Kawanokuchi J., Sonobe Y., Takeuchi H., Mizuno T., Suzumura A. Fractalkine attenuates excito-neurotoxicity via microglial clearance of damaged neurons and antioxidant enzyme heme oxygenase-1 expression. J. Biol. Chem. 2011, 286:2308-2319.
33. G93A) mutation induce wild-type motor neuron degeneration in vivo. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:17803-17808.
34. Pascual O., Ben Achour S., Rostaing P., Triller A., Bessis A. Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:197-205.
35. Persson M., Pekna M., Hansson E., Rönnbäck L. The complement-derived anaphylatoxin C5a increases microglial GLT-1 expression and glutamate uptake in a TNF-alpha-independent manner. Eur. J. Neurosci. 2009, 29:267-274.
36. Pintor A., Galluzzo M., Grieco R., Pèzzola A., Reggio R., Popoli P. Adenosine A2A receptor antagonists prevent the increase in striatal glutamate levels induced by glutamate uptake inhibitors. J. Neurochem. 2004, 89:152-156.
37. Ragozzino D., Lauro C., Limatola C. Role of CX3CL1 in synaptic activity and neuroprotection. Chemokine Receptors and NeuroAIDS 2010, 301-316. Springer, New York. O. Meucci (Ed.).
38. Romera C., Hurtado O., Mallolas J., Pereira M.P., Morales J.R., Romera A., Serena J., Vivancos J., Nombela F., Lorenzo P., Lizasoain I., Moro M.A. Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection. J. Cereb. Blood Flow Metab. 2007, 27:1327-1338.
39. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P., Welty D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996, 16:675-686.
40. Rothstein J.D., Patel S., Regan M.R., Haenggeli C., Huang Y.H., Bergles D.E., Jin L., Dykes Hoberg M., Vidensky S., Chung D.S., Toan S.V., Bruijn L.I., Su Z.Z., Gupta P., Fisher P.B. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 2005, 433:73-77.
41. Schlag B.D., Vondrasek J.R., Munir M., Kalandadze A., Zelenaia O.A., Rothstein J.D., Robinson M.B. Regulation of the glial Na+-dependent glutamate transporters by cyclic AMP analogs and neurons. Mol. Pharmacol. 1998, 53:355-369.
42. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008, 3:1101-1108.
43. Soriano S.G., Amaravadi L.S., Wang Y.F., Zhou H., Yu G.X., Tonra J.R., Fairchild-Huntress V., Fang Q., Dunmore J.H., Huszar D., Pan Y. Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury. J. Neuroimmunol. 2002, 125:59-65.
44. Takahashi K., Prinz M., Stagi M., Chechneva O., Neumann H. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Med. 2007, 4:e124.
45. Tilleux S., Hermans E. Down-regulation of astrocytic GLAST by microglia-related inflammation is abrogated in dibutyryl cAMP-differentiated cultures. J. Neurochem. 2008, 105:2224-2236.
46. Tilleux S., Goursaud S., Hermans E. Selective up-regulation of GLT-1 in cultured astrocytes exposed to soluble mediators released by activated microglia. Neurochem. Int. 2009, 55:35-40.
47. Uwechue N.M., Marx M.C., Chevy Q., Billups B. Activation of glutamate transport evokes rapid glutamine release from perisynaptic astrocytes. J. Physiol. 2012, 590:2317-2331.
48. von Bernhardi R., Eugenín J. Microglial reactivity to beta-amyloid is modulated by astrocytes and proinflammatory factors. Brain Res. 2004, 1025:186-193.
49. Wu J., Lee M.R., Choi S., Kim T., Choi D.S. ENT1 regulates ethanol-sensitive EAAT2 expression and function in astrocytes. Alcohol. Clin. Exp. Res. 2010, 34:1110-1117.
50. Wu J., Lee M.R., Kim T., Johng S., Rohrback S., Kang N., Choi D.S. Regulation of ethanol-sensitive EAAT2 expression through adenosine A1 receptor in astrocytes. Biochem. Biophys. Res. Commun. 2011, 406:47-52.
51. Zujovic V., Benavides J., Vigé X., Carter C., Taupin V. Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation. Glia 2000, 29:305-315.